{"id":49757,"date":"2024-05-14T08:00:50","date_gmt":"2024-05-14T00:00:50","guid":{"rendered":"\/\/www.gsbet888.com\/?p=49757"},"modified":"2024-05-13T13:51:23","modified_gmt":"2024-05-13T05:51:23","slug":"angew%ef%bc%9a%e9%9d%9e%e6%b4%bb%e5%8c%96%e6%9c%ab%e7%ab%af%e7%83%af%e7%83%83%e5%8f%82%e4%b8%8e%e7%9a%84%e5%af%b9%e6%98%a0%e9%80%89%e6%8b%a9%e6%80%a7%e6%b0%ae%e6%9d%82%e7%8e%af%e4%b8%99%e7%83%b7","status":"publish","type":"post","link":"\/\/www.gsbet888.com\/%e5%8c%96%e5%ad%a6%e6%9d%82%e8%ae%b0\/recentpaper\/2024\/05\/angew%ef%bc%9a%e9%9d%9e%e6%b4%bb%e5%8c%96%e6%9c%ab%e7%ab%af%e7%83%af%e7%83%83%e5%8f%82%e4%b8%8e%e7%9a%84%e5%af%b9%e6%98%a0%e9%80%89%e6%8b%a9%e6%80%a7%e6%b0%ae%e6%9d%82%e7%8e%af%e4%b8%99%e7%83%b7.html","title":{"rendered":"Angew\uff1a\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u53c2\u4e0e\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66"},"content":{"rendered":"

\u4f5c\u8005\uff1a\u6749\u6749<\/p>\n

\u5bfc\u8bfb\uff1a<\/h4>\n

\u8fd1\u65e5\uff0c\u4e2d\u56fd\u79d1\u5b66\u9662\u6df1\u5733\u5148\u8fdb\u6280\u672f\u7814\u7a76\u9662\u7684\u738b\u5b88\u56fd\u8bfe\u9898\u7ec4\u5728Angew. Chem. Int. Ed.<\/em>\u4e2d\u53d1\u8868\u8bba\u6587\uff0c\u62a5\u9053\u4e00\u79cd\u5168\u65b0\u7684Cpx<\/sup>Rh(III) (cyclopentadienyl-rhodium(III))-\u50ac\u5316\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u4e0eN<\/em>-pivalolyloxy sulfonamides (\u6c2e\u5bbe\u6e90)\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66\uff0c\u8fdb\u800c\u6210\u529f\u5b8c\u6210\u4e00\u7cfb\u5217\u624b\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5206\u5b50\u7684\u6784\u5efa\u3002<\/p>\n

Chiral Cpx<\/sup>Rhodium(III)-Catalyzed Enantioselective Aziridination of Unactivated Terminal Alkenes<\/p>\n

J. Wang, M. Luo, Y. Gu, Y. Liu, Y. Qin, S. Wang, Angew. Chem. Int. Ed<\/em>. 2024<\/strong>, ASAP. doi: 10.1002\/anie.202400502<\/a>.<\/u><\/p><\/blockquote>\n

\"\"<\/p>\n

\u6b63\u6587\uff1a<\/h4>\n

\u5728\u8fc7\u53bb\u7684\u51e0\u5341\u5e74\u91cc\uff0c\u624b\u6027Cpx<\/sup>Rh(III)-\u50ac\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66\u5df2\u6210\u4e3a\u5bf9\u6620\u9009\u62e9\u6027C-H\u5b98\u80fd\u56e2\u5316\u53cd\u5e94\u7684\u4e00\u79cd\u5f3a\u5927\u7b56\u7565[1]<\/sup>(Scheme 1A)\u3002\u540c\u65f6\uff0c\u624b\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u9aa8\u67b6\u5e7f\u6cdb\u5b58\u5728\u4e8e\u5404\u7c7b\u5929\u7136\u4ea7\u7269\u4ee5\u53ca\u751f\u7269\u6d3b\u6027\u5206\u5b50\u4e2d (Scheme 1E)\u3002\u8fd1\u5e74\u6765\uff0c\u8bf8\u591a\u7814\u7a76\u56e2\u961f\u5df2\u7ecf\u6210\u529f\u8bbe\u8ba1\u51fa\u591a\u79cd\u8fc7\u6e21\u91d1\u5c5e\u50ac\u5316\u70ef\u70c3\u4e0e\u4e0d\u540c\u6c2e\u5bbe\u6e90\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66[2]<\/sup> (Scheme 1B)\u3002\u7136\u800c\uff0c\u6b64\u7c7b\u53cd\u5e94\u4e3b\u8981\u96c6\u4e2d\u4e8e\u5728\u82ef\u4e59\u70ef\u3001\u03b1<\/em>,\u03b2<\/em>-\u4e0d\u9971\u548c\u7fb0\u57fa\u5316\u5408\u7269\u4ee5\u53ca\u4e00\u4e9b\u7279\u5b9a\u7684\u5e95\u7269\u3002\u53d7\u5230\u8fd1\u5e74\u6765\u5bf9\u4e8e[Ind*<\/sup>RhCl2<\/sub>]2<\/sub>-\u50ac\u5316\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66[3]<\/sup> (Scheme 1C)\u4ee5\u53caCpx<\/sup>Rh(III)-\u50ac\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66[4]<\/sup>\u76f8\u5173\u7814\u7a76\u62a5\u9053\u7684\u542f\u53d1\uff0c\u8fd9\u91cc\uff0c\u4e2d\u56fd\u79d1\u5b66\u9662\u6df1\u5733\u5148\u8fdb\u6280\u672f\u7814\u7a76\u9662\u7684\u738b\u5b88\u56fd\u8bfe\u9898\u7ec4\u62a5\u9053\u4e00\u79cd\u5168\u65b0\u7684Cpx<\/sup>Rh(III)-\u50ac\u5316\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u4e0eN<\/em>-pivalolyloxy sulfonamides\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66\uff0c\u8fdb\u800c\u6210\u529f\u5b8c\u6210\u4e00\u7cfb\u5217\u624b\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5206\u5b50\u7684\u6784\u5efa (Scheme 1D)\u3002<\/p>\n

\"\"<\/p>\n

\u9996\u5148\uff0c\u4f5c\u8005\u91c7\u7528N<\/em>-pivaloyloxy tosylamide 1<\/strong>\u4e0e\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c32a<\/strong>\u4f5c\u4e3a\u6a21\u578b\u5e95\u7269\uff0c\u8fdb\u884c\u76f8\u5173\u53cd\u5e94\u6761\u4ef6\u7684\u4f18\u5316\u7b5b\u9009 (Table 1)\u3002\u8fdb\u800c\u786e\u5b9a\u6700\u4f73\u7684\u53cd\u5e94\u6761\u4ef6\u4e3a\uff1a\u91c7\u75281a<\/strong>\u4f5c\u4e3a\u5e95\u7269\uff0cRh1<\/strong>\u4f5c\u4e3a\u50ac\u5316\u5242\uff0cCs2<\/sub>CO3<\/sub>\u4f5c\u4e3a\u78b1\uff0c\u5728HFIP\u53cd\u5e94\u6eb6\u5242\u4e2d\uff0c\u53cd\u5e94\u6e29\u5ea6\u4e3a\u5ba4\u6e29\uff0c\u6700\u7ec8\u83b7\u5f9790%\u6536\u7387\u7684\u4ea7\u72693a <\/strong>(91% ee<\/em>)\u3002<\/p>\n

\"\"<\/p>\n

\u5728\u4e0a\u8ff0\u7684\u6700\u4f73\u53cd\u5e94\u6761\u4ef6\u4e0b\uff0c\u4f5c\u8005\u5206\u522b\u5bf9\u4e00\u7cfb\u5217\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u5e95\u7269 (Scheme 2)\u4ee5\u53caN<\/em>-pivalolyloxy sulfonamides\u5e95\u7269 (Scheme 3)\u7684\u5e94\u7528\u8303\u56f4\u8fdb\u884c\u6df1\u5165\u7814\u7a76\u3002<\/p>\n

\"\"\"\" \"\"\"\"<\/p>\n

\u4e4b\u540e\uff0c\u8be5\u5c0f\u7ec4\u901a\u8fc7\u5982\u4e0b\u7684\u4e00\u7cfb\u5217\u7814\u7a76\u8fdb\u4e00\u6b65\u8868\u660e\uff0c\u8fd9\u4e00\u5168\u65b0\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u7b56\u7565\u5177\u6709\u6f5c\u5728\u7684\u5408\u6210\u5e94\u7528\u4ef7\u503c (Scheme 4)\u3002<\/p>\n

\"\"<\/p>\n

\u57fa\u4e8e\u4e0a\u8ff0\u524d\u671f\u76f8\u5173\u7684\u6587\u732e\u62a5\u9053[3]<\/sup>\uff0c\u4f5c\u8005\u63d0\u51fa\u5982\u4e0b\u5408\u7406\u7684\u53cd\u5e94\u673a\u7406 (Scheme 5A)\u3002\u63a5\u4e0b\u6765\uff0c\u4f5c\u8005\u5bf9\u4e0a\u8ff0\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u8fc7\u7a0b\u7684\u53cd\u5e94\u673a\u7406\u8fdb\u884c\u8fdb\u4e00\u6b65\u7814\u7a76 \u00a0(Schemes 5B-5C)\u3002\u540c\u65f6\uff0c\u4f5c\u8005\u8fd8\u63d0\u51fa\u5982\u4e0b\u5408\u7406\u7684\u7acb\u4f53\u5316\u5b66\u6a21\u578b (Scheme 5D)\u3002<\/p>\n

\"\"\"\"<\/p>\n

\u603b\u7ed3\uff1a\u4e2d\u56fd\u79d1\u5b66\u9662\u6df1\u5733\u5148\u8fdb\u6280\u672f\u7814\u7a76\u9662\u7684\u738b\u5b88\u56fd\u8bfe\u9898\u7ec4\u62a5\u9053\u4e00\u79cd\u5168\u65b0\u7684Cpx<\/sup>Rh(III)-\u50ac\u5316\u975e\u6d3b\u5316\u672b\u7aef\u70ef\u70c3\u4e0eN<\/em>-pivalolyloxy sulfonamides\u7684\u5bf9\u6620\u9009\u62e9\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5316\u53cd\u5e94\u65b9\u6cd5\u5b66\uff0c\u8fdb\u800c\u6210\u529f\u5b8c\u6210\u4e00\u7cfb\u5217\u624b\u6027\u6c2e\u6742\u73af\u4e19\u70f7\u5206\u5b50\u7684\u6784\u5efa\u3002\u8fd9\u4e00\u5168\u65b0\u7684\u5bf9\u6620\u9009\u62e9\u6027\u5408\u6210\u8f6c\u5316\u7b56\u7565\u5177\u6709\u5e95\u7269\u8303\u56f4\u5e7f\u6cdb\u3001\u4f18\u826f\u7684\u5b98\u80fd\u56e2\u517c\u5bb9\u6027\u4ee5\u53ca\u4f18\u826f\u7684\u5316\u5b66\u9009\u62e9\u6027\u4e0e\u5bf9\u6620\u9009\u62e9\u6027\u7b49\u4f18\u52bf\u3002<\/p>\n

\u53c2\u8003\u6587\u732e\uff1a<\/strong><\/h4>\n